Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).
Clinical trial NCT02054286 · COMPLETED
Trial details
- NCT number
- NCT02054286
- Sponsor
- Theravectys S.A.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2014-08-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.